PBYI News and Press, Puma Biotechnology Inc From 02/21/20

Image source: The Motley Fool. Puma Biotechnology Inc   (NASDAQ: PBYI) Q4 2019 Earnings Call Feb 20, 2020 , 4:30 p.m. ET Operator Continue reading

Puma Biotechnology, Inc. (PBYI) Q4 2019 Earnings Conference Call February 20, 2020 4:30 PM ET Company Participants Mariann Ohanesian - Senior Director of Investor Relations Alan Auerbach - Chief Executive Officer, President & Chairman Maximo Nougues - Chief Financial Officer ...

Puma Biotechnology (NASDAQ: PBYI ): Q4 Non-GAAP EPS of $0.01 beats by $0.27 ; GAAP EPS of -$0.29 beats by $0.19 . Revenue of $62.9M (-11.5% Y/Y) beats by $2.94M . Press Release More news on: Puma Biotechnology, Inc., Earnings news and commentary, Healthcare stocks news,

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2019. Unless otherwise stated, all comparisons are for the fourth quarter and full year 2019, compared to the fourth quarter and full year 2018....

Picking home-run stocks -- or stocks capable of generating exponential returns on capital -- is no easy matter. That being said, there has arguably never been a more favorable environment for risk-tolerant investors on the hunt for unusual growth opportunities.  The fact of the matter is t...

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Thursday, February 20, 2020, following release of its fourth quarter and full year 2019 financial results. The call may be accessed by dialing 1-877-709-8150...

Gainers:  Myomo (NYSEMKT: MYO ) +98% . More news on: Myomo, Inc., VIVUS, Inc., Predictive Oncology Inc., Stocks on the move, , Read more ...

Shares of Puma Biotechnology (NASDAQ: PBYI) , a small-cap cancer company, are absolutely on fire this morning. Specifically, the biotech's shares gained as much as 38% right out of the gate Wednesday. Puma's shares are still up by a healthy 32% as of 9:46 a.m. EST. What's driving this eye-po...

February 5, 2020 Palm Beach, FL –February 5, 2020 – Acute Myeloid Leukemia (AML) research has seen great progress with more researchers are now studying the causes, diagnosis, and treatment of Acute myeloid leukemia (AML) at many medical centers, university hospitals, an...

Company Overview Puma Biotechnology ( PBYI ) is a pharmaceutical company producing drugs used in cancer treatments. Their main product is Nerylinx, a compound used to treat breast cancer, specifically those that are HER-2 positive. The company has seen much volatility in terms of earning...